Cargando…

Radiotherapy in nodal oligorecurrent prostate cancer

OBJECTIVE: The current article encompasses a literature review and recommendations for radiotherapy in nodal oligorecurrent prostate cancer. MATERIALS AND METHODS: A literature review focused on studies comparing metastasis-directed stereotactic ablative radiotherapy (SABR) vs. external elective nod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinkawa, Michael, Aebersold, Daniel M., Böhmer, Dirk, Flentje, Michael, Ghadjar, Pirus, Schmidt-Hegemann, Nina-Sophie, Höcht, Stefan, Hölscher, Tobias, Müller, Arndt-Christian, Niehoff, Peter, Sedlmayer, Felix, Wolf, Frank, Zamboglou, Constantinos, Zips, Daniel, Wiegel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219546/ https://www.ncbi.nlm.nih.gov/pubmed/33914101 http://dx.doi.org/10.1007/s00066-021-01778-1

Ejemplares similares

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
por: Müller, Arndt-Christian, et al.
Publicado: (2022)

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020)

Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
por: Shelan, Mohamed, et al.
Publicado: (2021)

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer: Statement from the DEGRO working group prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2020)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022)

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions
por: Ghadjar, Pirus, et al.
Publicado: (2012)

Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy
por: Cihoric, Nikola, et al.
Publicado: (2012)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
por: Wegener, Daniel, et al.
Publicado: (2022)

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure
por: Geretschläger, Andreas, et al.
Publicado: (2015)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study
por: Goldblum, David, et al.
Publicado: (2008)

Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial
por: Lorton, Orane, et al.
Publicado: (2023)

Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma
por: Geretschläger, Andreas, et al.
Publicado: (2012)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Combining (68)Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
por: Kirste, Simon, et al.
Publicado: (2021)

Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
por: Stefan A. Koerber, et al.
Publicado: (2020)

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review
por: Yaney, Alexander, et al.
Publicado: (2022)

Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option
por: Zimmermann, Michel, et al.
Publicado: (2016)

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer()
por: Levy, Antonin, et al.
Publicado: (2023)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2023)

Node Oligorecurrence in Prostate Cancer: A Challenge
por: Zapatero, Almudena, et al.
Publicado: (2023)

Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation
por: Guckenberger, Matthias, et al.
Publicado: (2012)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy
por: Henkenberens, Christoph, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
por: Kissel, Manon, et al.
Publicado: (2019)

Tailored total lymphoid irradiation in heart transplant patients: 10-years experience of one center
por: Ghadjar, Pirus, et al.
Publicado: (2010)

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
por: Dirix, Piet, et al.
Publicado: (2023)

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
por: Triggiani, Luca, et al.
Publicado: (2017)

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking
por: Ghadjar, Pirus, et al.
Publicado: (2008)

Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience
por: Oehler, Christoph, et al.
Publicado: (2019)

Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2014)

PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
por: De Bruycker, A., et al.
Publicado: (2020)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
por: Macagno, Alban, et al.
Publicado: (2022)

An 87-year-old patient with repeated oligorecurrences over six years whose disease were treated with radiotherapy alone
por: Yun, Hyong Geun
Publicado: (2014)

Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’
por: Bravo, Isabel
Publicado: (2018)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q50gflonmij22tcd1s9rvd49a6